Bristol-Myers Squibb Company (BMY)
|
37.03
+0.54 (+1.48%)
|
|
|
|
BMY analyst ratings
Market Data powered by QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Filings and Fundamentals by Morningstar, Insiders by Vickers (USA) and SEDI(CDN), analyst ratings by Zacks.
BMY price and earnings targets
Market Data powered by QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Filings and Fundamentals by Morningstar, Insiders by Vickers (USA) and SEDI(CDN), analyst ratings by Zacks.
Special Offers
BMY earnings
Date
Actual
Expected
Prev Yr Qtr
10/24/2012
0.41
0.42
0.61
7/25/2012
0.48
0.48
0.56
4/26/2012
0.64
0.63
0.58
Bristol-Myers Squibb Company (BMY) Upgrades
Date
Analyst
Old Rating
New Rating
08/31/2010
Jefferies
Hold
Buy
06/11/2010
Citi
Hold
Buy
06/11/2010
Citi
Hold
Buy
03/05/2010
Morgan Stanley
Equalweight
Overweight
12/10/2008
Citi
Hold
Buy
10/08/2008
Merrill Lynch
Underperform
Buy citing valuation
Bristol-Myers Squibb Company (BMY) Downgrades
Date
Analyst
Old Rating
New Rating
09/24/2010
An analyst at Hapoalim Securities
Hold
Sell this morning
01/04/2010
Citi
Buy
Hold
10/09/2009
Cowen & Co
Outperform
Neutral
08/28/2009
Morgan Stanley
Overweight
Equalweight
12/16/2008
Merrill Lynch
Buy
Neutral
01/31/2008
S& P Equity Research
Buy
Hold
Bristol-Myers Squibb Company (BMY) New Coverage
Date
Analyst
Rating
09/11/2012
Credit Suisse
Neutral
05/18/2012
BMo Capital
Outperform
12/22/2009
Hapoalim Securities
Sell
07/15/2009
Morgan Stanley
Overweight
07/18/2008
Citi
Neutral
